RIBOSCIENCE LLC
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 586 Total Citation Count
- Jun 11, 2002 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9895442 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationMay 15, 14Feb 20, 18[C07H, A61K]
9708357 4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationDec 17, 12Jul 18, 17[A61K, C07H, A01N, C12N]
9694028 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationFeb 02, 16Jul 04, 17[C07H, A61K]
9370569 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationFeb 06, 15Jun 21, 16[C07H, A61K]
9249176 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationMay 15, 14Feb 02, 16[C07H, A61K]
9108999 2′, 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationDec 17, 12Aug 18, 15[C07H, A61K]
8648054 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replicationApr 12, 13Feb 11, 14[A61K]
7608601 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replicationJul 15, 04Oct 27, 09[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.